Episode #1 Future of AI In Drug Development- Guest Malai Sankarasubbar from Saama Technologies
May 29, 2018 ·
20m 9s
![Episode #1 Future of AI In Drug Development- Guest Malai Sankarasubbar from Saama Technologies](https://d3wo5wojvuv7l.cloudfront.net/t_square_limited_480/images.spreaker.com/original/264e7a89d4ccc0f9f7cfe3341885ffaa.jpg)
Download and listen anywhere
Download your favorite episodes and enjoy them, wherever you are! Sign up or log in now to access offline listening.
Description
QCR Global Group is a niche life science management consulting firm, hosting thought leaders on an array of topics in industry. With a primary mission of providing enlightened academic exchange...
show more
QCR Global Group is a niche life science management consulting firm, hosting thought leaders on an array of topics in industry. With a primary mission of providing enlightened academic exchange with change innovators to maximize the cross professional understanding of methods while improving the exchange of information that benefits industry experts and their consumers. Hosted by Dr. D. Orozco, President of the Life Science Practice and Principal Manager at QCR, each thought leader provides a quick explanation of what he/she specializes in, challenges and benefits based on case representation, along with insightful strategies from their angle of the profession.
In our premier episode we discuss the Future of AI in Drug Development with our guest, Malai Sankarasubbar. Mr. Sankarasubbar is the VP of AI at Saama Technologies, a global life science data analytics company.
show less
In our premier episode we discuss the Future of AI in Drug Development with our guest, Malai Sankarasubbar. Mr. Sankarasubbar is the VP of AI at Saama Technologies, a global life science data analytics company.
Information
Author | QCR GLOBAL GROUP |
Website | - |
Tags |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company